Considering the role of these three molecules in lung cancer pathology, the main goal of this study was to assess their serum concentration before and after treatment and investigate how MGP, Gas6, EGFR, and VK1 are modified after one cycle of chemotherapy. The gene discussed is EGFR; the disease is lung carcinoma.